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Inrreasos in dama creatine kinaw.MB 1MLt CKI w@r@ 
correlated wiih thr om@t of coronary artery repwhicion 
determined angiogrophicn!t)- in 32 patients with acute mya. 
@Wdi@l inerction who were trea!ed witt. r@combi”s”’ h”- 
man tissw-typ pt@mdnag@n *cfiwdor W-PAL Repafu- 
@ion occurred in 11 170%) ar*ll patients with I@h anterior 
desrendiog @@r@nary artery wclwion and in 8 (73%) of I I 
palkms with right coronary artery oxctwi@n. One paii@nt 
ha* pprrtstent tert c*rc”nlR@x coronary arwy occl~~io”. 
Plasma MB CK I.“$. ,radiaimmu”“mPlric asay) did nat 
in@r@@@@ sipllitkantty iha Qati@ntS with p@rsiEt@nt orctusion, 
but incnasod by a mea” t+ SEMI @f I * 1 and 6 + I times 
OY@l pretr@atnent lCY@lS at the end Of ttlr inRIion in 
patients with a reprrfurcd ten anterior dereending and 
right cw@n@,y arfwy, respectivety. When a ~l.~~fotd 
increue in MB CR t@v@t~ @t the end of the r&PA inkion 
was taken as @vid@nce of repslwinn of the krt anteriw 
de5cending @aronlry mtery, 13 ,93?c, Of 14 patirnts ailh 
reperfurian and 5(83%, of6 wilh prrsistent occt”\io” wrrr 
@orr@rtty identified. When a z2.2~Cold incr@w in MB CK 
levels was used to identify right corowry artery reperfu- 
sian, sewn tWo) of right patirntr with r@p@rrusion and 
three (100%) ni throw patient5 With perrirtent wctusion 
were correctly identitird. Tk s@“riti”tty and specificity of 
these indexes. dWi”@d from and spptted to Ihe IImP tmli@“f 
group. we,: 91 and 89%. reystiwly. 
Ttw index@@ were then applied pro~prctivdy to 16 
pli0p.t~ uith @nt@rtor, 16 with inferior and 5 with infera- 
prmerinr inlarction in whom MB CK w@s sssayod bath 
b&r@ and @t completion of a 90 min rt.P& infurion and 
c@r@ri~ry angiagraphy perfornwd al 90 min. (II 13 patients 
uithan!arior inLrction@nda patent lellanteriordecrendini! 
coronaii arterv. I2 192%) dem@Wratd a :-2.5-fold in- 
1: 1WS) t@rted with the radioimmur~om@tric assay. ‘The 
r@nsitiiit> and rpciticity of Ihr immunubnctianal assay 
w@r@ 83 2nd tW’o, r@sp@ctiwIy. 
I, A,” Co,, Canliol 1988:11:72p-Y, 
restore blood flow to i>chcmic mytcardium. improve vcntric- 
ular function nod reduce mortality (I-4). Because the potcn- 
iial benefits of this therapy dcpcnd to a large eslen, on the 
prompt restoration oi myccafdial perfusion. lbc limircd 
apphcahilily of iniracoronary rh-ombolysis with its require- 
mcnt for emergency caidw cdlheterization and its concom- 
itam time delay hat become apparent (5). 
In the absence of angiqraphic documentation. reliable 
methods arc needed to detect coronary repetiusion rapidly 
and oooinvaavelv. Clinic.d swn such as abrupt abatement 
oichcat pain. w;dcn oc.urence 01 “rcperfuchn” arrhyth- 
miac and resolution oi electrocardiographic IECGI ST seg 
men, changes are conventionally used. but remain equivocal 
as mdicalors of rcpcrfusion. Early washout and peaking of 
plasma ireatinc kiaarc levels aitcr coronary rcperfusion 
have been documcmcd as il meilns to ldentily coroocry 
artrry rcperiusior (6). hut tbcrc ib tignificani overlap with 
nonrepufu~ed arwrie~. 2nd Ihe lime to peak creatinc kinasc 
levels afler rcprri’uurion (8 to I I hoors in some patientsI (7) 
mny bc so del;,yed o\ to preclude further therapeutic intcr- 
vcmion 
clinica! uwiulo~~s of th!s approach. 
AI prcvxt. ~,pccific. npid end poim assaya for MB CK arc 
awlable (IUI. ho1 s!ud~es corrclaling early washom of MB 
The level of Ihe MB isoenzymc form of crcclinc kinase 
(MB CKI uwslly remains wilhm the normal raw in plasma 
within Ihe first 4 10 8 hours after (be ooset of myocardial 
miarcuan in the abwncc of repctiusian (8). Ailer reperiu- 
sion. the piarma MB CK concenfration also increases more 
rapIdly. but the l,mc 10 perk MB CK IS so dclaycd. preclud- 
in8 rehable detection of coronary rcperfusion. The MM-3 
form of crcatme kmase. which is released from tissue and 
conrerlcd by hydroly\;r in the blood to MM-2 end MM-I 18). 
is r:gnificantly rlcvacd within I5 to 30 min after repcrfusion. 
peimmiog a reliable eslimale of its owe1 WI. Avnilable 
lcchniqucs for crcafine kinabe MM isoform determination 
we. howcvcr. rclawcly lime-consumiog. requiring an anal- 
ysis ijmc of aooiuhimatele 90 rrin (91. thus rcducinr the 
Methods 
. . 
angiographically before treatment. Patients with cardiogenic 
Study patients (Group I). The first study group consisted 
of 32 patients (Table I) referred from the emergency ward 
within 6 h of the on~ct of chest pain from a suspected first 
shock or child-bearing potential were excluded. Informed 
myacardial inlarctiun. All patients met the following criteria: 
I) acute transmural myocardial infarction with ST segment 
written consent was obtamrd from all patients. This study 
elevation 20. I mV in at least two adjacent ECG leads. 21 age 
570 yczrs. 31 no contraindication to thrombolytic therapy. 
and 41 comolete coronarv arterv occlusion documented 
CK III plaw,a. conoomivan! with l<c o&l of repcrfusion 
during thrombolytic Iheropy. are lacking. lo Ihe presenl 
study. WC corrclalcd change\ m MB CK in blood with the 
oosct of coronary anery reperlu\ion durmg inlrnvenous 
thrombolyuc lheropy will, rccombrnam hunan liwuype 
p!a\mmogeen activ,wr Irt-PA). In ii first reuo\prctivc phase. 
wlid MB CK aw,y, and repeated coronary angiography 
wcrc performed m 32 p;menrr wlh acute myncurdml iniarc- 
bon and complete coronxy onery occluww lndcxcr for an 
incww m MU CK dcrivcd lrom lhis \Ludy wcrc then 
pro~peruvci~ opphcd 10 on additional group of 37 palvats 
uho rcccivcd ioirxwwu~ rt-PA fur :ICU!C myocordial miwc. 
tion. and in ulwm coronary repcllown wax uxrlirmcd 
;Ingiirgtl~pb~uallg. 
was conducted within the framework oia protocol approveh 
by the Bureau of Biologics of the U.S. Food and Drug 
Administration and by our hospital subcommi!tee on human 
studies. 
Treatment. After initial stm&+rd trcatmcnt. the padents 
underwent prctrcatmenf coronary angiography by the Jud- 
kina technique immediately after systemic heparinization 
(S.wO V bolw). After denwnstralion of complc~c coronary 
aray occlusion. rl.PA lGll021 or GI 1035. supplied by 
Gcncntech. Inc.l was infused intravenously using a constant 
rate miu\ian pump. Dow of It-PA ranged from 4 to II &kg 
per min for 90 min. im dewnhed previously (I I). Patients 
with penistent ucclu\iuo ailcr the initial intrwcnou~ throm- 
bulylic ininion of rl-PA were eligihlc for trc,~tmcm WUOU 
U bolus followed by 4,WO Lilmin for 60 mm) wrh m,ra- 
corunary streptokinare (Hoechrt-Roussel Pharmaceutxal?,. 
Angtogrsphic evaluation. Coronary angiography of !he 
occluded artery was performed a, I5 min intcrvak durmg the 
r&PA infusion and then I b after completion of ,hts therapy. 
Reperfusion was defined as complete distal opacdicatmo f 
the previously occluded coronary awry (Thrombalysin in 
Myncardial Infarction [TlMll grade 2 a 3) I I?). No rep+ 
fusion was defined as Ihe absence of anterograde Row of 
cnmrast medium Juring the thrombolytic infusion (T&it 
grade 0 or I). 
Bbod sampling. Arterial blood camples inr measuremen, 
of MB CK concentrations were collected before the wrt of 
the I?-PA infusion and subsequently at IS min m,ervals 
during and far I h after cessation of the infusion. All samples 
were hid immed,a,elv on ice and nrommlv ccmrihed a, 
2,300’~ g for 5 min.‘The plaxrm. from blood sample\ 
collected in 0.05 ml ltS‘51 of liwd ethvlenediaminetctraare- . 
ta,e. WBP then transferred to palystyrene test tuber and 
frozen a, -20°C until aseayed. 
Creatbte kinw MB assays. Levels of MB CK were 
determined by a ndio~mmunometric way using a double 
antibody technique (13) (Quick-MB. Internadonal tmmu- 
“oassay Laboratories. Inc.). Resultr are reported in equw 
alent units per lilrr iEU/li,erl. 
Prospecfive Study 
Study patients (Gruup II). The second rtudy group con- 
sisted of 37 patients (Table I1 with ac~:,e myocardial mfarc- 
tion with entry criteria and thrombaly,ic therapy identical 10 
those afthe first group except lhar I) !n,rwennus r,-PA wil, 
started immediatel, in the cmrrgency ward. and 2) pretrrat- 
me”, ccronary an;mgraphy was not performed. Coronary 
angiography was pelformed u, ?5 ;md 90 min after ihc >!hn of 
the n-PA infusion. Bloud samples ior MB CK mea~uremrm 
were obrained before and at the end of the r&PA infusion. 
Creetine kinuse MB de,erminalion with n rapid end point 
aa*. The validity of MR CK determination 1s a noninva- 
we ,cdica:cF of cornnary ;eperiusion was first ertablished 
by using the radiaimmunomexic asay in both the re,rorpec- 
we sod the prospective studier. However. wnh an analyw 
lime 260 m!a. the clinical usefulness oftids assay for oromp, 
evaluatmn of coronary arverv reperfusion is limhcd. There- 
fort. a rapId immunbiunc,i&~ MB CK assay was alw 
,es,ed. Stored blood samples obtamed before and a, :he end 
ui the rt-PA mfusion from ?9 of the 32 patiemr in ,he 
prospecwe study (Group 111 were reasnayed. LiveI\ of MB 
CK were determined from its B-subunit ac,wi,y after mh:- 
bition ui all M-subum, a~wty wnh an antibody by the 
method of Wirrrburg et al. (10). wnh the use of the Boehr- 
ingcr Munnheim Diagnosticr kit. The analgs~s umc for 
plasma wmples with this method is IS mm with the s:andard 
procedure. but may be easily reduced tn approximately IO 
ms”. 
Statisr’cal analvsb. Resultr are exnressed as mean .: 
standard devration (SD1 or. when m&ted. as mean : 
rtandcrd crrur uf rhe mean ISEM). Analyw of the effect9 of 
rsoerfwoc on MB CK levels were done using I wsts that 
ccmoared the level of MB CK before thrombalvtic lheraov 
v&a that after rep&&n. The comphiinons are bawd on 
either the ratio of the 90 min tn the pretreatment \amplc or 
on the rate of increase in MB CK before and after repcrfu- 
SIO” Because several I led camprmsonr were mad<. a 
Bonierrom correction war applied 10 the p va!ues. and 
resuh> were declared statistically significant when ihe twn- 
laded p values are <O.Ol. 
Coronary thrombatysir nnd plasma MB CL actirily f’fnbte 
2A, Fig. 1). The rate of increace in MB CK in plasma. 
dewrmmed with the radiuimmunometric as%y iu the ab- 
sence of reperfuusion was very FLOW. A sudden rapid increase 
anwwnphically documeolcd coronary artery rcpcrfu- 
van. Data wc reported as man wlucz ? SEM (vcrdca1 
b,wI. The timcaxk IS a1iwd 10 she onrcl alrspcfiurion 
in patients with wccerrful trcstmenl (top se&I rnd !o 
Ihe onw ol r&PA infwion in padrnt~ with pcr\ialeot 
coronary “CcIusio” ,bottam SC.ICI. . _ plticmb with 
coronary ancry repcrfusion: n = padents with persist. 
cm coronary occlusion: A = patients wh persistent 
uEclu*ion after N-PA infusion who had reperfunon 
within 60 min of adminirtradon of intracoronary strep- 
lokininc. 
mm aller;~n~togr;lphraliy documenled coronary rcpsrfusion 
(I, = 0 ofill. Thi\ raoid mcr~asc in MB CK ~~~~alboobserved 
In four paucms who wcrc not responsive 10 n-P*. in whom 
rcpctiuww wa\ mduced with mlracoronary wcptokinase. 
The ratio of Ihe MB CK lcvcl at w min IO the prctrcatmcnl 
VBIUC was s~gmficanlly grcawr in patient, with lhan in those 
witboul rcpcrfur~on Ip = 0.0021. In the 14 patients with a 
recanalircd Icfl w&or dcaccnding coronary awry. the MB 
CK level !+‘a\ 8 ? I umes (mean _ SEMI I&ha at Ihc cod 
of the inbs~on as compared wilh the orciofusion value. The 
relalive mcrcasc m MB CK in patients with a reperfused 
right ccronxy artery occlusion was 6 i I timcc grcawr than 
the pr~rcatmcs: v&w: in patients with pcl-sistcnl left sole- 
rior ilcxendino or * cht comnarv rv occlubion. Ibis 
~“crca\c NBS oiy 2 +‘a.3 and I i 0.1 d&s. rcspectivcly. 
Whca a r2.5.fold increase in MB CK levels al the end ofthc 
Coronary thrombolysis and MB CK activity (Table LB). 
When the indexes of an increase in MB CK. derived 
from the retrospective study. were prospectively applied lo 
a group of 32 patienls 116 with anterior and I6 with inferior 
myocardial inbrclion). I? 192%) of I3 patients with anterior 
infarction and a patent left anterior descending corooary 
ancry at Ihe end of the n-PA infusion had a 22.5.fold 
increase in htB CK, whereas all 3 patients with anterior 
infarction and persistent occlusion had a smaller increase. 
Likewise. a cutoff point of a 22.2.fold increase in MU CK in 
patvats with inferior infarction correctly idendfied 10 (77%) 
of 13 patients with a pntcnt right coronary anery. whereas all 
3 patienir with penislent occlusion had a smaller increase. 
Thor. in the prospective study. the overall specificity of Ihc 
indexes of an incteiw in MB CK derived from the rcfro- 
Oh mfu\lon. al cumpared wilh the prctrearment value. speclivc study was IIN% (6 of 6 palients with persistem 
ka$ taken a\ evidcncr, of coronary artery rcpcrfusion in occlusion were ccrrectly identified). and the sensitivity was 
!nalie~r wth lefl anlcrix descending coronary artery occlu- 8SJ (22 of 26 palients wiih patent infarct-related arteries 
rion. an o$:imi :vslalion with angingraphic rcwli* was wcrc corrcclly identified). 
oblamcti. Indeed. I3 (93%) of 14 pilticntb with angiographi- 0: five patients with inkroposlerior in[arclion. three had 
tally documenled rcpcrfw~on had a 22.5~fold incrcax in a patent left circumflex coronary artery and a 22.5.told 
MB CK. and > (Usi) of 6 patients with persistent occlusion increase in MB CK. whcrcaa !wo pa!iea with a persistent 
had a <? 5.fo!d incrcasc In the group wilh righl coronary circumflex occlusion had i( <Z-fold inaease. 
artery uccIu)ion. a cutoR poiol of a 22.2.fold mcrcasc Monitoring of romnnry artery reperfusion during rerom- 
corrtx~l~ idenlilied 7 (88%) of 8 palwnl, with rcperfusion. binant human tirswlype plarminogen ctivalor inlusion wilb 
and all 3 paucntx with pcnislenl occluswn had a vnailcr a rapid end point ereatine kinaa MB assay (Table 3). Crea. 
u~crc~~x Wilh lhcx oplirnizcd ,:uloff mlios. derived from 
and apphed to the same pLicnl group, Ihe overall apccificity 
tine kinase MB was irassayed with a rapid endpoint. ammo- 
of Ilie MB CK Indexer wn 89% (I of 9 puienls with 
nofunctional assay on the preinfusion and W min bample~ 
pdrFiaw occlusion traj inaorrrctly idcntificd), and the 
from 29 of rhe 32 patients with rmlcrior or inferior infaction 
rens~t~,~l! was 9l?$ I! of 22 pa~cnts with reperfwion were 
(G~OUQ 111 enrolled in the pro~~eot~~c study from whom 
incorrectly tdcntlfierl). One pahcnl with penislent occlusmn 
plasma samples wcrc rtdl awlable. Applying a cutoff pain! 
of H r2.5.fold increax as an index of left anterior descend. 
of the lcfl circumflex coronary arlery had Q <?.fold increw 
in MU CK. 
ink corone:y arlcry rcpcrfusion in patient\ with anterior 
myocardial infwction and a r2.2.fold incrwsc for right 
infarction is~likely to’&& whemx n~yocardwn and 
reduce monahty if 1:eatment is ;ni!,sl-d carig ,,-$,i+ 171 
ln,nvenous lherapy that avoids Ihc delay .trrow!cd v.‘:h 
cardiac cathelerization is ,he only !iavh!e approach lilr 
rapid and efficient tbrombolylic therapy applicable on B large 
scale. Hawever, only coronary angiog&.phy is curren$ 
availat!c for :e!iable dacxocoi&m of able coronil~y a. 
wry rcpafurion. Widespread use of inlravenous thrombuly. 
tic treatmen, for acure myocarrhal mfcrctlon reqwres lhc 
availabilify of reliable noninvasive indiwors of rcpcrfuwn 
,o avoid mandatory coronary angiography m all pa,ienl\ 
Corrtlalion beiween increase in crea:ine kinase MB and Ihe 
onset of coronw ar,ew nowfusion. In ihe oraen, x,ady in 
patients with docurne&d’coronary awry dcchr;ion irralcd 
with inlravenbus rt-PA within 6 hour, x:,er ,hc onset of 
symptoms, WC observed a close corre,a,m,, between ihu 
early increassd rate oi appearance of ;rca!ine kinase-MB 
(MB CK) in plasma and ,he onset of repafuvon. Ihl\ 
correlation is consirlen, and signilcantly different from the 
slow appwance of MB CK III ,ne ahsence of reperfu,ion 
Thus. the rclalive increase in MB CK durme. the 90 min 
period of r,-PA infusion may provide an carI; dnd rehahle 
index of wronxy artery reperlwon. 
Slighily aiffercn, cu,off pomts for increases in MB CK 
were axd for oplimal d,scrimina,ion hrwecn reperf~~oa or 
persi;,en, occlusion of Ihc left an,erior descendmg wru\ 
the ngh, coronary .+r,ery Thus lindmg wti no, wrpnrmg in 
view of the greater prevalence of well developed collater.~- 
lization in the right coronary rrtcry cilculawm hed. frc- 
Cnuxs of dlscr&ey belween crenline kinaw MB increae 
nod coronary ar,cry repcrfwion. Some limi,alionL, of ,hc we 
of hlH CK lc~eli as an indica!or of wpxfuvon may pw:ol 
A!I p.irlen,\ \*ilh won~ry anery reperforlon may not >how 
li an;lcienl ~ncrcavc in MB CK by the end of Ihe mfueon 
hccawc <I, Ihc ma,, pr:sencc of suhfolal occIuw. well 
dsieloped culla,c:al orculauon or cychc repcrfurion ;and 
~~tixlwon. Shcse I;c,ori may allow ~on~muour washout of 
the enrya~c ;and limit progrewion of OC’FIO’JS. Such patient< 
rn:ly be ldenlified hy addibonal clinical vgn\ and cymp,om\ 
wch a\ 1% pronounced ST qmen, elevation. \to!,ermg 
cher, pam or cyclic change, m ST segment elevation. 
Alterna,~veiy. pafientr with pcrwten, occlusion may Fhow a 
timlied incrc.w in MB CK. par:xul;wly of the ixtiatmn of 
therapy i, delayed or if the mfnrc, ~onr i\ extcnwe Rapid 
MB CK wa~hou, may aI50 he obwved in palienlr who hew 
initial rcper’wion. but who then experience aculc coronary 
rci&won However, as obwved I” ,he prew, iludy. ,hc 
hgh dcgrcc of ww,ivi,y and rpecific0y of the mcreax in 
MB CK in dcrrcting coronary alrery reperfwion wggc%i 
,ha, wch dircrepancics bei*ccil ,hr MB CK rerponrc awl 
rcperfwon will occur in only a lionfed number of patients. 
Rcwcw of the clinical cosne of the vii palwnfs with 
coronary x,ery reperfovon or .la,en, Infarct-rclatcd ai,ericr 
who dc,non\,ra,ed an mcreav in MB CK lradioimmuno- 
me,r!c ~i()! helow ,he cutoff valus~ yleldcd the fol:oiving 
polentiai cxplan;&an~ for ,hese dircrcpanucr. ‘The Iwo 
rpechve sludy. one pahen~ was treated for a second in&t 
I yea, after an exwnaive first infarcr in the same location. 
Two of IhC remammg p?.,icnta had bnrderlmc ST regmen, 
elevation of 0 I mV In the sixth patient. no plawble 
explanation for the di,crcpancy ~‘a found. In the one 
patient aith persistent left nnterior deacending anery occlu- 
sion who demonstated a 3.1.fold increase in MB CK. 
therapy wiis inwaled 6 h after Ihe onset of symploms and. 
thus, ihe time of lreahnenl may have overlapped with the 
onsel of rpontaneous release of MB CK. 
Potential tolue of crealine kinase-MB determination for 
noninvasive dctccfion ofroronsrj srte,) reperluaion. The use 
of MB CK arrays for nooinvasive monitoring of thmmboly- 
tic theraov oiacure mvocardial infarction with r&PA or other 
thrombolyric agents may be ,i$nificanl. Coronary angiogra- 
phy during Ihe early hours ofthrombolytic therapy is wither 
logistically feasible no, required in patienrs with successful 
repufurion. Indeed. in patients with reperfusion. stable 
